This week, BioFortis said that the Catalysis Foundation for Health has selected its Labmatrix database software system to manage an international tuberculosis diagnostic biomarker study funded by the Bill and Melinda Gates Foundation.

Specifically, CFH researchers and their collaborators will use the platform to collect and manage patient specimen data and clinical information, track shipment status, analyze data from thousands of patient biospecimens, and view real-time study results from pre-built or ad hoc data queries.